BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 33416144)

  • 1. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
    Wang ZZ; Luo YR; Du J; Yu Y; Yang XZ; Cui YJ; Jin XF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5206-5214. PubMed ID: 31298412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Knockdown of Fez family zinc finger protein 1 antisense ribonucleic acid 1 (FEZF1-AS1) inhibits invasion and migration of esophageal squamous cell carcinoma cells by blocking JAK2/STAT3 pathway].
    Cao Y; Wang X; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):317-324. PubMed ID: 32519669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
    Zhao X; Tang YP; Wang CY; Wu JX; Ye F
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion.
    Wang B; Liang T; Li J
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4524-4531. PubMed ID: 30058683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA TTTY15 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging microRNA-337-3p to upregulate the expression of JAK2.
    Wang W; Yang J
    Anticancer Drugs; 2020 Nov; 31(10):1038-1045. PubMed ID: 32868648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.
    Wei S; Sun S; Zhou X; Zhang C; Li X; Dai S; Wang Y; Zhao L; Shan B
    Carcinogenesis; 2021 Feb; 42(2):315-326. PubMed ID: 33095847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation.
    Zhang M; Tian H; Li R; Yan W; Xu R
    Pharmazie; 2018 Jun; 73(6):342-348. PubMed ID: 29880087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy.
    Li M; Meng X; Li M
    Aging (Albany NY); 2020 Jun; 12(12):12107-12118. PubMed ID: 32554852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression.
    Liu H; Zhou Y; Fredimoses M; Niu P; Ge Y; Wu R; Liu T; Li P; Shi Y; Shi Y; Liu K; Dong Z
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131966. PubMed ID: 38697422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
    Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
    Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis.
    Shi Y; Fang N; Li Y; Guo Z; Jiang W; He Y; Ma Z; Chen Y
    Cancer Sci; 2020 Aug; 111(8):2824-2836. PubMed ID: 32495982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite Motif-containing Protein 11 Silencing Inhibits Proliferation and Glycolysis and Promotes Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Inactivating Signal Transduction and Activation of Transcription Factor 3/c-Myc Signaling.
    Xuan T
    J Physiol Investig; 2024 Jan; 67(1):37-46. PubMed ID: 38780271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.